Switzerland’s Acino pharmaceutical group has signed a license agreement with Dutch Biocare Copenhagen A/S, the manufacturer of probiotics, and would present the Optilakt fifth generation probiotic line in Ukraine.
Acino said in a press release that the probiotic will appear in the Ukrainian pharmacy chain in February 2018. The financial conditions of the deal are not disclosed.
According to the conditions of the license agreement, Acino will be the exclusive representative of three products of this trademark in Ukraine until 2022 inclusively.
Acino Ukraine Director General Yevhen Zaika said that in 2017, Acino entered the pediatrics segment, signing the distribution agreement with France’s Laboratoires Gilbert SAS being authorized to sell and promote some over-the-counter medicines in Ukraine.
